Ted Buchan & Co Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Ted Buchan & Co lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,900 shares of the healthcare conglomerate’s stock after buying an additional 229 shares during the quarter. UnitedHealth Group makes up about 1.5% of Ted Buchan & Co’s holdings, making the stock its 20th biggest holding. Ted Buchan & Co’s holdings in UnitedHealth Group were worth $3,090,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG lifted its holdings in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock valued at $133,373,000 after purchasing an additional 9,872 shares in the last quarter. Cohen & Steers Inc. lifted its holdings in shares of UnitedHealth Group by 36.1% during the fourth quarter. Cohen & Steers Inc. now owns 656 shares of the healthcare conglomerate’s stock valued at $332,000 after purchasing an additional 174 shares in the last quarter. Finally, Jump Financial LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $1,321,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $271.92 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a 50-day moving average price of $289.37 and a 200 day moving average price of $401.34. The stock has a market capitalization of $246.27 billion, a P/E ratio of 11.78, a P/E/G ratio of 1.69 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.3%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. Hsbc Global Res downgraded UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. KeyCorp lowered their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Truist Financial lowered their target price on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating on the stock in a report on Wednesday, July 16th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Hold” and an average price target of $366.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.